THEMIS MEDICARE
|
The Current P/E Ratio of THEMIS MEDICARE is -29.62.
| Share Price | ₹77.6 | Feb 02,2026 |
| Market Cap | ₹714.2 Cr | |
| Earnings-TTM | ₹-24.1 Cr | TTM-Consolidated Results |
| Price/Earnings | -29.62x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of THEMIS MEDICARE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹714.2 Cr] as on Feb 02,2026
(/) Earnings [ ₹-24.1 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -29.62x ]
Thus, for THEMIS MEDICARE , the investors are currently willing to pay -29.62 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of THEMIS MEDICARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of THEMIS MEDICARE over the last five years.
Historical PE (Price/Earnings) ratio chart of THEMIS MEDICARE
PE Ratio Performance Analysis for THEMIS MEDICARE
- THEMIS MEDICARE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 19.07x.
- THEMIS MEDICARE 's operated at median p/e ratio of 1.89x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, THEMIS MEDICARE 's p/e ratio peaked in Mar2024 at 46.31x.
- THEMIS MEDICARE 's p/e ratio hit its five-year low in Mar2021 of 0.72x.
How does THEMIS MEDICARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| THEMIS MEDICARE | -24.11 | -29.62 | 714.2 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 35.53 | 390,828.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 63.67 | 158,227.0 |
| CIPLA LTD | 4,544.70 | 23.32 | 105,961.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 63.11 | 135,045.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 17.91 | 98,682.5 |
| MANKIND PHARMA LTD | 1,767.06 | 48.29 | 85,330.9 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 17.79 | 88,473.1 |
| LUPIN LTD | 4,347.53 | 22.37 | 97,270.2 |
| AUROBINDO PHARMA LTD | 3,447.75 | 19.80 | 68,250.0 |
| ABBOTT INDIA LTD | 1,508.95 | 38.47 | 58,046.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs THEMIS MEDICARE 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | -29.62x |
| Max industry PE | 63.67x |
| Median industry PE | 23.32x |
| Average industry PE | 29.15x |
You may also like the below Video Courses